Pictet Asset Management
VERA icon

Pictet Asset Management’s Vera Therapeutics VERA Stock Holding History

Pictet Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3M Sell
1,051,583
-340,838
-24% -$14.7M 0.04% 344
2025
Q4 		$70.5M Sell
1,392,421
-46,700
-3% -$1.66M 0.07% 271
2025
Q3 		$41.8M Buy
1,439,121
+666,307
+86% +$15.4M 0.04% 357
2025
Q2 		$18.2M Sell
772,814
-67,444
-8% -$1.52M 0.02% 532
2025
Q1 		$20.2M Sell
840,258
-1,055
-0.1% -$33.9K 0.02% 497
2024
Q4 		$35.6M Buy
841,313
+269,315
+47% +$11.9M 0.04% 367
2024
Q3 		$25.3M Sell
571,998
-51,651
-8% -$1.96M 0.03% 425
2024
Q2 		$22.6M Sell
623,649
-387,901
-38% -$15.4M 0.03% 439
2024
Q1 		$43.6M Sell
1,011,550
-316,990
-24% -$11.3M 0.05% 335
2023
Q4 		$20.4M Buy
1,328,540
+102,393
+8% +$1.3M 0.02% 483
2023
Q3 		$16.8M Buy
+1,226,147
New +$21M 0.02% 501

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pictet Asset Management's VERA Position: Q1 2026 in Review

Pictet Asset Management reduced its Vera Therapeutics (VERA) stake by 24% in Q1 2026, selling an estimated $14.7M and leaving 1,051,583 shares worth $42.3M. The position accounts for 0.04% of the portfolio, ranked #344.

Pictet Asset Management first reported a position in VERA in Q3 2023 and has held it in 11 quarters since. The position peaked at $70.5M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Pictet Asset Management held 1,051,583 shares of Vera Therapeutics worth $42.3M as of Q1 2026.
  • Pictet Asset Management sold 340,838 Vera Therapeutics shares in Q1 2026, an estimated $14.7M.
  • Vera Therapeutics made up 0.04% of Pictet Asset Management's portfolio in Q1 2026, its #344 holding.
  • Pictet Asset Management first reported a position in Vera Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Vera Therapeutics position peaked at $70.5M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.